MicroRNA Expression Profiles in Thyroid Tumors
- 8 April 2009
- journal article
- review article
- Published by Springer Nature in Endocrine Pathology
- Vol. 20 (2), 85-91
- https://doi.org/10.1007/s12022-009-9069-z
Abstract
MicroRNAs (miRNAs) constitute a recently identified class of small endogenous noncoding RNAs that act as negative regulators of the protein-coding gene expression and may impact cell differentiation, proliferation and survival, i.e., all fundamental cellular processes implicated in carcinogenesis. miRNA expression is deregulated in many types of human cancers, including thyroid cancer. The purpose of this review is to summarize the existing findings of miRNA deregulation in thyroid tumors and its potential role in thyroid cancer biology and molecular diagnostics.Keywords
This publication has 44 references indexed in Scilit:
- Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosisExpert Review of Molecular Diagnostics, 2008
- MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycleEndocrine-Related Cancer, 2007
- Specific microRNAs are downregulated in human thyroid anaplastic carcinomasOncogene, 2007
- MicroRNAs in cell proliferation, cell death, and tumorigenesisBritish Journal of Cancer, 2006
- The role of microRNA genes in papillary thyroid carcinomaProceedings of the National Academy of Sciences, 2005
- MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulationProceedings of the National Academy of Sciences, 2005
- RAS Is Regulated by the let-7 MicroRNA FamilyCell, 2005
- MicroRNA genes are transcribed by RNA polymerase IIThe EMBO Journal, 2004
- Nuclear Export of MicroRNA PrecursorsScience, 2004
- The nuclear RNase III Drosha initiates microRNA processingNature, 2003